Float Short %

1.5

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

15.07

Target Price

14.76

Analyst Recom

2.85

Performance Q

13.56

Relative Volume

0.88

Beta

0.34

Ticker: RDY

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-06-02	RDY	0	21.13	1.79
2025-06-03	RDY	0	21.13	1.79
2025-06-04	RDY	0	21.13	1.79
2025-06-05	RDY	0	21.13	1.79
2025-06-06	RDY	0	21.13	1.79
2025-06-09	RDY	0	21.09	1.79
2025-06-10	RDY	0	21.09	1.79
2025-06-11	RDY	0	21.09	1.71
2025-06-12	RDY	0	21.09	1.71
2025-06-13	RDY	0	21.09	1.71
2025-06-16	RDY	0	20.87	1.71
2025-06-17	RDY	0	20.87	1.71
2025-06-18	RDY	0	20.87	1.71
2025-06-20	RDY	0	20.87	1.71
2025-06-23	RDY	0	20.88	1.71
2025-06-24	RDY	0	20.88	1.71
2025-06-25	RDY	0	20.88	1.71
2025-06-26	RDY	0	20.88	1.50
2025-06-27	RDY	0	20.88	1.50
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

20.88

Beta

0.34

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

14.76

P/E

18.82

Forward P/E

23.3

PEG

P/S

3.26

P/B

3.22

P/Free Cash Flow

36.33

EPS

0.8

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

17.32

Relative Volume

0.88

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Dr. Reddy's Laboratories Ltd

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 27811

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; and research and development of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

stock quote shares RDY – Dr. Reddy’s Laboratories Limited Stock Price stock today

news today RDY – Dr. Reddy’s Laboratories Limited stock forecast ,stock prediction 2023 2024 2025

marketwatch RDY – Dr. Reddy’s Laboratories Limited yahoo finance google finance

stock history RDY – Dr. Reddy’s Laboratories Limited invest stock market

stock prices RDY premarket after hours

ticker RDY fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: RDY

No data found

No data found

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y